BioMarin Pharmaceutical Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BMRN | BBIO | IONS | KRYS | RARE | LGND | |
|---|---|---|---|---|---|---|
| Market cap | 10.72B | 12.85B | 7.26B | 9.83B | 1.51B | 6.20B |
| P/E (TTM) | 149.7 | — | — | 41.6 | — | 32.8 |
| Forward P/E | 8.3 | 2,275.1 | -39.3 | 35.8 | 25.8 | 26.0 |
| Price/book | 1.7 | -5.1 | 16.4 | 7.2 | -5.2 | 6.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +5.57% | +16.37% | −35.85% | +79.50% | −51.66% | +67.77% |
| Today | +1.09% | +0.61% | −3.56% | +0.14% | −1.16% | +3.09% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BMRN news ›Bank of America Securities Sticks to Its Buy Rating for BioMarin Pharmaceutical (BMRN)
Bank of America Securities analyst Jason Gerberry maintained a Buy rating on BioMarin Pharmaceutical today and set a price target of $86.00. Gerberry covers the Healthcare sector, focusing on stocks such as Merck & Company, Eli Lilly & Co,…
Biomarin Pharmaceutical Inc
Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets → BioMarin appears attractively valued at current levels. With a 13.7% upside to…
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
Shares of biotech company BioMarin Pharmaceutical (NASDAQ: BMRN) jumped 3.3% in the afternoon session after the company agreed to acquire Alesta Therapeutics, a clinical-stage biotech company. According to a company press release, BioMarin…
BioMarin Stock Slips As Pipeline Hype Fails To Impress
BioMarin Pharmaceutical ( (BMRN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement. For longer-term investors, BioMarin’s strong revenue growth, raised guidance, and healthy cash generation…
Sweetgreen Announces Lauren Crowley as Chief People Officer
Sweetgreen (NYSE: SG) appointed Lauren Crowley as Chief People Officer, effective October 26, 2026, reporting directly to CEO Jonathan Neman. LOS ANGELES--(BUSINESS WIRE)-- Sweetgreen, Inc. (NYSE: SG), the mission-driven restaurant brand…
Lila Bio Expands Leadership Team with Kimberly Ma, M.S., as Chief Development Officer
BioSpace Lila Bio Expands Leadership Team with Kimberly Ma, M.S., as Chief Development Officer Radiopharmaceutical development leader brings over two decades of global oncology clinical experience to Lila Bio, including senior roles at…
Metagenomi (NASDAQ:MGX) & BioMarin Pharmaceutical (NASDAQ:BMRN) Head to Head Comparison
Posted by Michael Walen on Oct 4th, 2026 Metagenomi (NASDAQ:MGX – Get Free Report) and BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two…
BioMarin Pharmaceutical | Science & Technology
BioMarin Pharmaceutical (2026) ‘BioMarin Announces New Three-Year VOXZOGO Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026’, BioMarin Pharmaceutical. BioMarin Pharmaceutical (2026) ‘BioMarin Provides Update on Phase 3 Trial…
Profluent And BioMarin Pharmaceutical Inc. Partner To Design Novel Medicines Using AI
marketscreener.com Profluent announced a collaboration with BioMarin Pharmaceutical Inc to design and optimize novel enzyme therapies for BioMarin's pipeline Under the agreement, Profluent will apply its foundational AI models to generate…
BioMarin Pharmaceutical Adds Independent Director to Board
An update from BioMarin Pharmaceutical ( (BMRN) ) is now available. On September 10, 2026, BioMarin Pharmaceutical Inc. expanded its Board of Directors from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., as an independent…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com2
-
theglobeandmail.com2
-
247wallst.com1
-
biospace.com1
-
markets.financialcontent.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.